BA, MA (Boston), PhD (Duke)
Professor, Pathology and Laboratory Medicine, Medicine, Chief Medical & Scientific Officer, Canadian Blood Services, Associate Member, Biochemistry and Molecular Biology, Medicine
Dana Devine is currently the Chief Scientist at Canadian Blood Services. She is also a Professor of Pathology and Laboratory Medicine at the University of British Columbia, and a founding member of the University’s Centre for Blood Research where she is currently the Centre director. Dr. Devine completed her research training at Duke University in North Carolina where she obtained the Ph.D. degree. She has a longstanding research career in blood products, transfusion medicine, platelet biology, complement biochemistry, and coagulation.
Dana provides directional advice to the senior management team, of which she used to be a part when she led the Medical Services & Innovation division at Canadian Blood Services. This position includes understanding whether Canada is falling behind other countries with respect to blood product offerings, and a move into the cellular therapies space.
Since joining Canadian Blood Services in 1999 as the executive director of research and development, she has played an integral role in a number of initiatives, particularly the development of the visionary Network Clinic for Advancement and Development Laboratory in Vancouver.
Dana holds a PhD in immunology from Duke University in North Carolina, and has more than 35 years of professional association with the University of British Columbia’s Faculty of Medicine as an educator and mentor in blood research.
- PhD (Immunology), Duke University, 1986
- MA (Biology), Boston University, 1981
- BA (Biology), Boston University, 1978
Awards and Recognition
- The general subject areas of research expertise of this laboratory are platelet biology, complement biochemistry and blood coagulation. Our particular experimental focus in transfusion medicine is in the area of blood product processing and storage. Ongoing research projects include studies of the storage lesion of platelet concentrates and methods to improve the quality of stored platelet concentrates. Most recently, we have sought to apply leading edge technology to these research questions, in particular through the application of proteomics technology to investigations of blood products.The research in the laboratory also includes a significant component of applied development work with projects related to practical solutions to issues arising in the manufacture of blood products including process control and quality enhancement through modification of production processes or through understanding more about the significance of the variability of donor characteristics. We have ongoing collaborations with other scientists in all of these areas as well as collaborations with companies working in the blood transfusion business.